SER-287, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS, PRODUCES REMISSION ASSOCIATED METABOLITES, REDUCES INTESTINAL EPITHELIAL IL-8 SECRETION AND PROTECTS EPITHELIAL BARRIER FUNCTION IN VITRO

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 160; no. 3; pp. S56 - S57
Main Authors Martínez, Asunción, Balasubramanian, Divya, Piña, Ambar, Kieser, Karen, Narendar, Priyanka, Abdulaziz, Ahmad, O’Brien, Edward, Henn, Matthew
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2021
Online AccessGet full text

Cover

More Information
ISSN:0016-5085
1528-0012
DOI:10.1053/j.gastro.2021.01.150